Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 31 for “"Lassa virus"”.
-
Development and characterization of Lassa virus vaccines and mouse model
Lassa virus (LASV) is the causative agent of a hemorrhagic fever endemic in West Africa, which results in over 200,000 infections and 3000 to 5000 deaths annually. It has previously been demonstrated that a live attenuated recombinant Vesicular Stomatitis Virus expressing the LASV glycoproteins …
-
Computational identification and mechanistic evaluation of novel Lassa virus entry inhibitors
Lassa virus, a zoonotic Old World mammarenavirus endemic to West Africa, causes significant disease burden and is a serious public health threat. With an estimated 2.7 million infections per year, it is categorized by the World Health Organization as a priority pathogen for research in emergency …
-
UNRAVELING THE ROLE OF LASSA VIRUS TRANSMEMBRANE DOMAIN IN VIRAL FUSION MECHANISM
Lassa virus (LASV) is the most prevalent member of the arenavirus family and the causative agent of Lassa fever, a viral hemorrhagic fever. Although there are annual outbreaks in West Africa and recently isolated cases worldwide, no current therapeutics or vaccines pose LASV as a significant global …
-
MAPPING EPITOPES AND RECEPTOR BINDING DETERMINANTS OF LASSA VIRUS GLYCOPROTEIN USING Qβ PHAGE DISPLAY
Lassa virus (LASV) is a highly infectious pathogen responsible for Lassa fever, a severe hemorrhagic disease endemic to West Africa. Despite its significant health burden, there are currently no widely available vaccines or effective antiviral treatments. The only surface glycoprotein (GP) of LASV …
-
Sero-prevalence of Ebola and Lassa virus in the Republic of Guinea, Macenta prefecture
Following the 2013-2016 West Africa Ebolavirus (EBOV) outbreak, a broad range of scientific research has been conducted to understand and prevent future epidemics. Our current study, supported by the United States Food and Drug Administration (FDA), uses sero-epidemiology to look at the foot-print …
-
PREVENTING THE NEXT PANDEMIC: ELUCIDATING THE ROLE OF THE LASSA VIRUS FUSION DOMAIN IN INFECTIONS
Infection with Lassa virus (LASV), an arenavirus endemic to West Africa, results in Lassa fever (LF) – a severe hemorrhagic fever with high morbidity and mortality. There are presently no FDA-approved therapeutic options for the explicit treatment of LF, largely due to a lack of knowledge …
-
Unlocking the Significance of the Stable Signal Peptide: A Vital Component of Lassa Virus Membrane Fusion
Lassa virus (LASV) is an arenavirus prevalent in West Africa that causes a severe hemorrhagic fever in infected humans with no approved therapeutics. One of the key steps in the LASV lifecycle is low pH-dependent membrane fusion, which is the process by which the viral and host membranes are merged …
-
Computational Surveillance and Molecular Analysis of Lassa Virus in Response to Increased Prevalence in Humans and Animals
Lassa fever, first identified in the late 1960s, is caused by Lassa virus (LASV), a Biosafety Level 4 (BSL-4) pathogen endemic to West Africa. It is estimated to cause approximately 300,000 infections and 5,000 deaths annually. Despite its public health impact, no licensed vaccine is currently …
-
Pichinde virus infection of outbred Hartley guinea pigs and mice as small animal models of human Lassa fever
Arenaviruses are viruses that can cause severe and deadly hemorrhagic fever infections in Africa and South America, including Lassa virus that causes Lassa fever in several countries in west Africa. There are currently no vaccines and very limited therapeutics available for Lassa fever. There are …
-
Pro-inflammatory cytokines promote viral replication and cell cycle mediators in arenavirus-induced hepatitis.
Lassa virus (LASV) is an arenavirus and causative agent of Lassa fever (LF), a viral hemorrhagic fever in West Africa for which there is no vaccine. Lymphocytic choriomeningitis virus (LCMV), is used as a surrogate to mimic LASV-induced liver pathology. LCMV-WE, not LCMV-ARM, causes disease in …
-
Utilizing blood-based biomarkers to characterize pathogenesis and predict mortality in viral hemorrhagic fevers
Hemorrhagic fever viruses are a major public health threat in Sub-Saharan Africa. These kinds of viruses cause symptoms ranging from non-specific fevers and body aches to severe, life-threatening bleeding, shock, and multi-organ failure. Previously discovered hemorrhagic fever viruses can cause …
-
Thermostability of lyophilized VSV-based vaccines
… to a cold chain. Success of vesicular stomatitis virus (VSV) based vaccines has been highlighted by its increased adoption by pharmaceutical companies and most importantly, the recently approved vaccine for high consequence Ebola virus (EBOV). Lujo virus (LUJV) and Lassa virus (LASV), both …
-
Mapping the glycan shields of enveloped viruses
… crucial biological roles. As obligate parasites, viruses exploit host-cell machinery to glycosylate their own proteins during replication. Viral envelope proteins form a myriad of human pathogens including HIV-1, influenza virus, Lassa virus, coronaviruses, Zika virus, dengue virus, and Ebola …
-
Crystallographic studies of the Crimean-Congo haemorrhagic fever virus and tomato spotted wilt virus N proteins
… is a group of segmented negative sense RNA viruses (sNSV) that cause severe disease in both plants and humans. This group of viruses is further classified into the Orthobunyavirus, Tospovirus, Nairovirus, Phlebovirus and Hantavirus genera. Crimean-Congo haemorrhagic fever (CCHF) is a …
-
Using the host immune response to hemorrhagic fever Viruses to understand pathogenesis and improve diagnostics
Hemorrhagic fever viruses cause severe infections characterized by a hyperactive immune response that often leads to multiorgan failure and death. Current diagnostic tests are based on detecting viral proteins and nucleic acids in the blood. These are late-stage events during infection, which makes …
-
ANIMAL MODELS FOR BEHAVIORAL CHANGES OR HEARING LOSS UPON ACUTE VIRUS INFECTIONS
… to sequelae, two genera of single stranded RNA viruses are of high importance to study as models of neurological sequelae; arenaviruses and alphaviruses. Both of these viruses are important human pathogens and the cause of the long-term neurological damage, the related pathology and the …
-
Development of a Lassa/Rabies virus vaccine based on the rabies vector
Lassa fever (LF), is a viral hemorrhagic fever caused by Lassa virus (LASV), for which neither an approved vaccine or effective treatment is available. LASV is an endemic virus in western Africa and a major health and economic burden, causing an estimate 100,000-300,000 infections yearly, with the …
-
Die Entwicklung sequenzbasierter Schnelldiagnostikverfahren zur Diagnostik von hochpathogenen Erregern
… Fieberviren, wie beispielsweise das Lassa Virus, CCHFV oder das Ebola und Marburg Virus sind hochkontagiös und gehen mit einer hohen Letalitätsrate einher, weshalb sie von besonderer Bedeutung für das klinische Management und den Bevölkerungsschutz sind. In Deutschland haben diese, …
-
Improving the care of Lassa fever patients: re-evaluating the use of Ribavirin and characterising cardiovascular function
<p>Lassa fever is a viral haemorrhagic fever, endemic to several West African countries. Case fatality rates average 30% across the literature. Ribavirin, a broad-spectrum antiviral agent, has been used to treat Lassa fever for four decades. Ribavirin is a pro-drug, metabolised to its active …
-
Analysis of Envelope Glycoprotein Complex of Arenaviruses
Arenaviruses, the causative agents of severe hemorrhagic fevers, are endemic in rodent populations and can be transmitted to humans by contact. Without effective treatment or licensed vaccines, these viruses pose serious public health and biodefense concern. The sole treatment option is the …
Page 1 of 2